comparemela.com

Latest Breaking News On - Pharmaceuticals - Page 6 : comparemela.com

ISM® REPORTS ECONOMIC IMPROVEMENT TO CONTINUE IN 2024

/PRNewswire/ Economic improvement in the United States will continue in 2024, say the nation s purchasing and supply management executives in the December.

United statesUnited kingdomAnthonys nievesKristinam cahillTimothyr fiorePublic administrationServices production or provision capacityServices growthPhotofinishing servicesServices business survey committeeManagement of companies support servicesServices change in overall employmentCare servicesInstitute for supply managementServices business revenuesDeath care services

BioNTX Celebrates Resilience and Innovation in North Texas Biosciences Ecosystem

/PRNewswire/ BioNTX, a leading bioscience and healthcare innovation trade organization and the North Texas life sciences industry applaud the vision and.

United statesKathleenm ottoPrnewswire bioKathleen ottoReata pharmaceuticals biogenReata pharmaceuticalsNorth texasMedical pharmaceuticalsHealth care amp hospitals

Antipsychotic Drugs Market Forecasts 2023-2028 - Market Set for Growth, Forecasted at CAGR of 5 94% from 2023 to 2028

/PRNewswire/ The "Antipsychotic Drugs Market Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com s offering. With mental health.

United statesLaura woodEli lillyOtsuka holdingsTeva pharmaceutical industriesOffice hours callE st office hours callBristol myers squibb companyPorter five force analysisDrugs market forecastsTopics coveredForecast yearsFive forceValue chainFree callHours call

Mission Therapeutics announces US FDA approval to initiate Phase II clinical trial of its lead asset MTX652 in Acute Kidney Injury

/PRNewswire/ Mission Therapeutics ("Mission" or the "Company"), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today.

United statesUnited kingdomSuhail nurbhaiPaul thompsonAnker lundemoseRoche venture fundDrug administrationMission therapeuticsIp groupPrnewswire mission therapeuticsInvestigational new drugAcute kidney injuryNorth americaChief executive officerChief medical officerChief scientific officer

Global Colonoscopy Devices Business Research Report 2023-2030: Market to Reach $2 2 Billion with Visualization Systems Accounting for $1 1 Billion

/PRNewswire/ The "Colonoscopy Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. Global Colonoscopy.

Laura woodOffice hours callGi view ltdKarl storz se coOlympus corporationHuger medical instrument co ltdSonoscape medical corporationHoya corporationSunny medical equipmentE st office hours callStrategic businessColonoscopy devices marketColonoscopy devicesVisualization systemsConventional colonoscopyVirtual colonoscopy

vimarsana © 2020. All Rights Reserved.